Bulletin
Investor Alert

New York Markets Close in:

Company Close Updates Archives | Email alerts

May 18, 2021, 5:01 p.m. EDT

Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

Shares of Inovio Pharmaceuticals Inc. INO rose 4.56% to $7.11 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.56% to 13,303.64 and Dow Jones Industrial Average DJIA falling 0.78% to 34,060.66. This was the stock's third consecutive day of gains. Inovio Pharmaceuticals Inc. closed $26.68 short of its 52-week high ($33.79), which the company reached on June 26th.

The stock outperformed some of its competitors Tuesday, as AbbVie Inc. ABBV rose 0.27% to $117.21, Amgen Inc. AMGN fell 0.60% to $250.86, and AstraZeneca PLC ADR AZN rose 0.20% to $55.99. Trading volume (7.2 M) remained 2.3 million below its 50-day average volume of 9.5 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Get news alerts on Inovio Pharmaceuticals Inc. — or create your own.
This Story has 0 Comments
Be the first to comment
More News In
Markets

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.